JP2008524123A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008524123A5 JP2008524123A5 JP2007545807A JP2007545807A JP2008524123A5 JP 2008524123 A5 JP2008524123 A5 JP 2008524123A5 JP 2007545807 A JP2007545807 A JP 2007545807A JP 2007545807 A JP2007545807 A JP 2007545807A JP 2008524123 A5 JP2008524123 A5 JP 2008524123A5
- Authority
- JP
- Japan
- Prior art keywords
- per liter
- concentration
- composition
- glutamine
- antioxidant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 15
- 239000003963 antioxidant agent Substances 0.000 claims 8
- 235000006708 antioxidants Nutrition 0.000 claims 8
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 8
- 230000003078 antioxidant effect Effects 0.000 claims 7
- 239000002552 dosage form Substances 0.000 claims 6
- 239000011669 selenium Substances 0.000 claims 6
- 229910052711 selenium Inorganic materials 0.000 claims 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims 3
- 230000004898 mitochondrial function Effects 0.000 claims 3
- 125000003748 selenium group Chemical group *[Se]* 0.000 claims 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 2
- 229930003268 Vitamin C Natural products 0.000 claims 2
- 229930003427 Vitamin E Natural products 0.000 claims 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims 2
- 235000013734 beta-carotene Nutrition 0.000 claims 2
- 239000011648 beta-carotene Substances 0.000 claims 2
- 229960002747 betacarotene Drugs 0.000 claims 2
- 150000001720 carbohydrates Chemical class 0.000 claims 2
- 235000014633 carbohydrates Nutrition 0.000 claims 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 2
- 150000002632 lipids Chemical class 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 235000019154 vitamin C Nutrition 0.000 claims 2
- 239000011718 vitamin C Substances 0.000 claims 2
- 235000019165 vitamin E Nutrition 0.000 claims 2
- 229940046009 vitamin E Drugs 0.000 claims 2
- 239000011709 vitamin E Substances 0.000 claims 2
- 239000011701 zinc Substances 0.000 claims 2
- 229910052725 zinc Inorganic materials 0.000 claims 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims 2
- 230000037396 body weight Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63765704P | 2004-12-21 | 2004-12-21 | |
| PCT/CA2005/001944 WO2006066404A1 (en) | 2004-12-21 | 2005-12-21 | Therapeutic nutrient compositions or combinations and methods of their use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012006251A Division JP2012107023A (ja) | 2004-12-21 | 2012-01-16 | 治療用栄養組成物又は組合せ、及びそれらの使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008524123A JP2008524123A (ja) | 2008-07-10 |
| JP2008524123A5 true JP2008524123A5 (https=) | 2008-08-21 |
Family
ID=36601322
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007545807A Pending JP2008524123A (ja) | 2004-12-21 | 2005-12-21 | 治療用栄養組成物又は組合せ、及びそれらの使用方法 |
| JP2012006251A Pending JP2012107023A (ja) | 2004-12-21 | 2012-01-16 | 治療用栄養組成物又は組合せ、及びそれらの使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012006251A Pending JP2012107023A (ja) | 2004-12-21 | 2012-01-16 | 治療用栄養組成物又は組合せ、及びそれらの使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080131525A1 (https=) |
| EP (1) | EP1841445A4 (https=) |
| JP (2) | JP2008524123A (https=) |
| CN (1) | CN101084003A (https=) |
| AU (1) | AU2005318832B2 (https=) |
| BR (1) | BRPI0519755A2 (https=) |
| CA (1) | CA2588911C (https=) |
| WO (1) | WO2006066404A1 (https=) |
| ZA (1) | ZA200705824B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10004762B2 (en) | 2013-05-08 | 2018-06-26 | Gambro Lundia Ab | Dialysis formulation |
| EP3490971A4 (en) * | 2016-08-01 | 2020-02-26 | Filament Biosolutions Inc. | METHODS OF TREATING AND PREVENTING SIDE EFFECTS OF CANCER TREATMENT |
| GB201811312D0 (en) * | 2018-07-10 | 2018-08-29 | Nuchido Ltd | Compositions |
| CN120420344B (zh) * | 2025-07-08 | 2025-09-05 | 中国人民解放军总医院第三医学中心 | 一种眼用药物组合物及其制备方法和应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6294520B1 (en) * | 1989-03-27 | 2001-09-25 | Albert T. Naito | Material for passage through the blood-brain barrier |
| DE4304172A1 (de) * | 1993-02-12 | 1994-08-25 | Bayer Ag | Fungizide Wirkstoffkombinationen |
| US5561111A (en) * | 1994-12-23 | 1996-10-01 | The University Of Virginia Patent Foundation | Stable glutamine derivatives for oral and intravenous rehydration and nutrition therapy |
| US6022867A (en) * | 1996-11-27 | 2000-02-08 | Showa Denko Kabushiki Kaisha | Method of administering vitamin E to animals and compositions containing tocopheryl phosphates and salts thereof for animals |
| DE69739663D1 (de) * | 1996-12-31 | 2009-12-31 | Antioxidant Pharmaceuticals Co | Pharmazeutische glutathionpräparate und methoden zu dern verabreichung |
| US5849335A (en) * | 1997-06-02 | 1998-12-15 | Nestec S.A. | Composition and method for providing glutamine |
| WO1999021565A1 (en) * | 1997-10-24 | 1999-05-06 | Cornell Research Foundation, Inc. | Nutritional supplement for cerebral metabolic insufficiencies |
| US6649746B1 (en) * | 1999-05-07 | 2003-11-18 | University Of Virginia Patent Foundation | Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes |
| US6805880B1 (en) * | 1999-08-20 | 2004-10-19 | Ferrosan A/S | Pharmaceutical delivery system for vitamin C and vitamin E and use of a combination of vitamin C and E for preventing or treating conditions involving oxidative stress |
| US6890896B1 (en) * | 1999-11-18 | 2005-05-10 | Ceremedix, Inc. | Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| AU5625001A (en) * | 2000-04-18 | 2001-10-30 | Societe Des Produits Nestle S.A. | Nutritional modules |
| US6479068B1 (en) * | 2000-06-30 | 2002-11-12 | Baxter International Inc. | Therapeutic nutrient regimen for alleviating mucositis, stomatitis and cachexia in oncology patients |
| DE10057290B4 (de) * | 2000-11-17 | 2004-01-08 | Fresenius Kabi Deutschland Gmbh | Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten |
| US6552076B2 (en) * | 2000-12-15 | 2003-04-22 | Mitokor | Compounds for altering mitochondrial function and cellular responses |
| PL363426A1 (en) * | 2001-03-09 | 2004-11-15 | Societe Des Produits Nestle S.A. | Composition improving age-related physiological deficits and increasing longevity |
| US6660293B2 (en) * | 2001-06-29 | 2003-12-09 | Everett Laboratories, Inc. | Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects |
| DE10151764A1 (de) * | 2001-10-19 | 2003-05-08 | Basf Ag | Kombination von Liponsäure und Glutamin in Lebens- und Arzneimitteln |
| JP2003192586A (ja) * | 2001-12-27 | 2003-07-09 | Ss Pharmaceut Co Ltd | ＩＬ−１β抑制剤 |
| DE10221403A1 (de) * | 2002-05-14 | 2003-12-04 | Kyberg Pharma Vertriebs Gmbh & | Diätetische und pharmazeutische Zusammensetzungen, ihre Herstellung und ihre Verwendung |
| US6645514B1 (en) * | 2002-12-19 | 2003-11-11 | Access Business Group International, Llc | Increasing skin cell renewal with water-soluble Vitamin E |
-
2005
- 2005-12-21 JP JP2007545807A patent/JP2008524123A/ja active Pending
- 2005-12-21 CA CA2588911A patent/CA2588911C/en not_active Expired - Fee Related
- 2005-12-21 BR BRPI0519755-4A patent/BRPI0519755A2/pt active Search and Examination
- 2005-12-21 AU AU2005318832A patent/AU2005318832B2/en not_active Ceased
- 2005-12-21 EP EP05823544A patent/EP1841445A4/en not_active Withdrawn
- 2005-12-21 ZA ZA200705824A patent/ZA200705824B/xx unknown
- 2005-12-21 US US11/792,587 patent/US20080131525A1/en not_active Abandoned
- 2005-12-21 WO PCT/CA2005/001944 patent/WO2006066404A1/en not_active Ceased
- 2005-12-21 CN CNA2005800440212A patent/CN101084003A/zh active Pending
-
2012
- 2012-01-16 JP JP2012006251A patent/JP2012107023A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gao et al. | Exploring the anti-cancer potential of Ganoderma lucidum polysaccharides (GLPs) and their versatile role in enhancing drug delivery systems: a multifaceted approach to combat cancer | |
| Rana et al. | Living life the natural way–Wheatgrass and Health | |
| JP2013523708A5 (https=) | ||
| CA2683786C (en) | Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects | |
| Al-Hussaniy et al. | Pharmacological properties of Spirulina species: Hepatoprotective, antioxidant and anticancer effects | |
| HRP20240034T1 (hr) | Liječenje kardiovaskularnih bolesti | |
| WO2007012022A3 (en) | Unit dose form with ibuprofen-famotidine admixture | |
| EP2216024A3 (en) | Use of Ranolazine for the treatment of cardiovascular diseases | |
| WO2011159100A2 (ko) | 항암 활성을 나타내는 약제학적 조성물 | |
| JP2011510922A5 (https=) | ||
| EP1922066A2 (en) | Topiramate compositions for treatment of headache | |
| WO2011019735A3 (en) | Nutritional supplements | |
| Lian et al. | Ganoderma lucidum spore oil synergistically enhances the function of cyclophosphamide in the prevention of breast cancer metastasis | |
| Hassan et al. | Therapeutic potential of betaine and its derivatives in cancer treatment: a comprehensive review | |
| US10946075B1 (en) | Radioprotection, radiomitigation and radiorecovery | |
| JP2008524123A5 (https=) | ||
| CA2688047A1 (en) | Composition of biocompatible microparticles of alginic acid for the controlled release of active ingredients by intravenous administration | |
| CN106491582A (zh) | 含二氢杨梅素的抗醉制剂及其用途 | |
| Erdmann et al. | Chemosensitizing effects of carbon-based nanomaterials in cancer cells: enhanced apoptosis and inhibition of proliferation as underlying mechanisms | |
| Park et al. | Angelica gigas Nakai extract ameliorates the effects of cyclophosphamide on immunological and hematopoietic dysfunction in mice | |
| Sak et al. | Chemomodulating effects of flavonoids in human leukemia cells | |
| Sekhar et al. | A review on anticancer potential of natural drugs: hispolon and limonene | |
| WO2011163321A3 (en) | Composition and method of treating lipid encapsulated virus infections | |
| WO2010142400A3 (de) | Zusammensetzungen auf basis von chitosan-oligosacchariden | |
| TW200626133A (en) | Oral medication for twice-daily administration |